Can we get more coverage on promising therapeutics about to go into trial like 2 Ph 2 trials oral host directed $BSGM drug MMPD alone &amp; in combo with $GILD REM with 
@mayoclinic #COVID19 chairman as Principal Inv + ex $CELG CMO &amp; $MRK vaccine head https://t.co/bFGiKSpXxc https://t.co/o1fB8kZPme